0 items USD 0.00Search
Your search for "gbi research frontier pharma chronic acute neuropathic pain gpcr nerve growth factor based" gave back 819845 results.
The pain management devices industry plays a crucial role in providing effective relief to individuals suffering from various types of pain,...
Catalog:
HJResearch
June 2023
Price: USD 3,200.00
A nerve biosimilar biological product is a biologic medical product in nervous area with high similarity to another biological medicine that already...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
A nerve biosimilar biological product is a biologic medical product in nervous area with high similarity to another biological medicine that already...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
The global Wearable Pain Management Device market size was valued at USD 1393.2 million in 2023 and is forecast to a readjusted size of USD 2740...
Catalog:
GIR
February 2024
Price: USD 3,480.00
Spinal cord stimulation (SCS) systems are indicated as an aid in the management of chronic, intractable pain of the trunk and/or limbs, including...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Spinal Column Stimulation (SCS) Systems market size is projected to grow from US$ 2054.3 million in 2022 to US$ 3613.7 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals. The global Non-Opioid Pain...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Spinal Column Stimulation (SCS) Systems market size is expected to reach $ 3644 million by 2029, rising at a market growth of 7.8% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The Acute Pain Service provides care for patients requiring specialised techniques of analgesia, such as Patient Controlled Analgesia (PCA, Opioid...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Ropivacaine mesylate is a long-acting amide local anaesthetic agent for a spinal block and effectively blocks neuropathic pain. Ropivacaine blocks...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Ropivacaine Mesylate market size is expected to reach $ 1357.2 million by 2029, rising at a market growth of 6.1% CAGR during the forecast...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Ropivacaine Mesylate market size is projected to grow from US$ 851.1 million in 2022 to US$ 1334.7 million in 2029; it is expected to grow...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Spinal Column Stimulation (SCS) Systems market size was valued at USD 2160.8 million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Market Analysis and Insights: Global Acute Pain Management Services Market The global Acute Pain Management Services market is projected to grow from...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals. Highlights The global Non-Opioid...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
